{"id":"NCT00412061","sponsor":"Novartis Pharmaceuticals","briefTitle":"Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor","officialTitle":"A Randomized, Double-blind Placebo-controlled, Multicenter Phase III Study in Patients With Advanced Carcinoid Tumor Receiving Octreotide Depot and Everolimus 10 mg/Day or Octreotide Depot and Placebo","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2010-04","completion":"2013-06","firstPosted":"2006-12-15","resultsPosted":"2012-03-12","lastUpdate":"2014-11-21"},"enrollment":429,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoid Tumor","Malignant Carcinoid Syndrome"],"interventions":[{"type":"DRUG","name":"Octreotide","otherNames":["Sandostatin LARÂ® Depot"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Everolimus","otherNames":["RAD001"]}],"arms":[{"label":"Octreotide+ Everolimus","type":"EXPERIMENTAL"},{"label":"Octreotide+ Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study was to evaluate whether everolimus 10 mg / day added to treatment with depot octreotide prolongs progression free survival compared to treatment with octreotide alone in patients with advanced carcinoid tumor.","primaryOutcome":{"measure":"Progression Free Survival (PFS) as Per Adjudicated Central Radiology Review","timeFrame":"Time from randomisation to dates of disease progression, death from any cause or last tumor assessment, reported between day of first patient randomised, 10 January 2007, until cut-off date 02 April 2010","effectByArm":[{"arm":"Octreotide+ Everolimus","deltaMin":16.43,"sd":null},{"arm":"Octreotide+ Placebo","deltaMin":11.33,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":70,"countries":["United States","Australia","Belgium","Canada","Czechia","Finland","France","Germany","Greece","Italy","Netherlands","Slovakia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["28444114","23187897","22119496"],"seeAlso":["http://www.novartisclinicaltrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":126,"n":215},"commonTop":["Diarrhoea","Fatigue","Nausea","Oedema peripheral","Stomatitis"]}}